Bank of Montreal vs Philip Morris International Inc. — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while Philip Morris International Inc. trades at $176.88 (market cap $280.84B). The key difference: Philip Morris International Inc. is far larger — about 2.3× Bank of Montreal's market cap, and Philip Morris International Inc. pays the higher dividend (3.26%). Which is the better fit depends on your goals.
| BMO | PM | |
|---|---|---|
Market Cap | $124.81B | $280.84B |
Sector | Financials | Consumer Staples |
52-Week High | $180.86 | $191.86 |
52-Week Low | $110.44 | $144.33 |
Dividend Yield | 2.77% | 3.26% |
Enterprise Value | — | $327.33B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 3.12% on the day, amid a recent profit forecast revision. The stock shows a bullish technical signal with key support at $175 and resistance at $183. Fundamentally, the company reported strong 2025 results with $40.65B revenue and $11.35B net income, though a $500M impairment charge and cost pressures prompted a lowered 2026 outlook. Analyst sentiment remains positive with a $194 consensus price target and 68% buy ratings.
The outlook is cautiously optimistic; earnings growth and the IQOS brand strength offer upside, but regulatory risks and illicit market pressures pose challenges. The current price presents a potential entry point below the analyst target, though investors must weigh margin pressures from energy costs and currency swings noted in recent company guidance.
Trailing returns across standard periods
Latest headlines on both assets
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →